A phase 2 randomized, double-blind, placebo-controlled, multicenter study of VS-6063 as maintenance therapy in subjects with malignant pleural mesothelioma which has not progressed on at least 4 cycles of pemetrexed/platinum therapy Meeting Abstract


Authors: Keegan, M.; Baas, P.; Fennell, D.; Gralla, R. J.; Kindler, H.; Krug, L. M.; Nowak, A. K.; Schwartz, L. H.; Horobin, J. C.
Abstract Title: A phase 2 randomized, double-blind, placebo-controlled, multicenter study of VS-6063 as maintenance therapy in subjects with malignant pleural mesothelioma which has not progressed on at least 4 cycles of pemetrexed/platinum therapy
Meeting Title: 15th World Conference on Lung Cancer (IASLC)
Keywords: mesothelioma; cancer stem cells; fak; nf2/merlin
Journal Title: Journal of Thoracic Oncology
Volume: 8
Issue: Suppl. 2
Meeting Dates: 2013 Oct 27-31
Meeting Location: Sydney, Australia
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2013-11-01
Start Page: S941
End Page: S942
Language: English
ACCESSION: WOS:000339624904247
PROVIDER: wos
DOI: 10.1097/01.JTO.0000438438.14562.c8
Notes: Meeting Abstract: P2.14-014 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Lee M Krug
    220 Krug
Related MSK Work